INHIBITORS OF HEPATITIS B VIRUS COVALENTLY CLOSED CIRCULAR DNA FORMATION AND THEIR METHOD OF USE

摘要

[0296] Pharmaceutical compositions of the invention comprise covalently closed circular DNA formation inhibitors having a disease-modifying action in the treatment of diseases associated with the formation of covalently closed circular DNA that include hepatitis B infection, and any disease involving formation of covalently closed circular DNA.